Indivior Pharmaceuticals, Inc. Shares Outstanding (Cover Page)
Indivior Pharmaceuticals, Inc. (INDV) had Shares Outstanding (Cover Page) of 118.01 million shares as of 2026-07-28, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-03
- 2026-07-28: Entity Common Stock, Shares Outstanding 118.01M shares.
- 2026-04-01: Entity Common Stock, Shares Outstanding 121.92M shares.
- 2026-01-31: Entity Common Stock, Shares Outstanding 125.07M shares.
- 2025-10-01: Entity Common Stock, Shares Outstanding 124.85M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-28 | 118.01M shares 10-Q · filed 2026-08-03 |
| 2026-04-01 | 121.92M shares 10-Q · filed 2026-04-30 |
| 2026-01-31 | 125.07M shares 10-K · filed 2026-02-26 |
| 2025-10-01 | 124.85M shares 10-Q · filed 2025-10-30 |
| 2025-07-01 | 124.77M shares 10-Q · filed 2025-07-31 |
| 2025-05-01 | 124.77M shares 10-Q · filed 2025-05-01 |
| 2025-03-01 | 124.66M shares 10-K · filed 2025-03-03 |
| 2023-12-31 | 136.53M shares 20-F · filed 2024-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |